Eyes absent homolog 2 in breast cancer: the relationship between molecular phenotyping and survival outcomes
Egyptian Journal of Pathology · 2025-07 · 45 (2) · 123-130
DOI: 10.4103/egjp.egjp_15_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Egyptian Journal of Pathology, online erschienen am 11.03.2026. Verfasst von Nisreen D.M. Toni und 2 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Breast cancer (BC) is considered one of the most frequent cancers worldwide. Eyes absent homolog 2 (EYA2) plays a crucial role in promoting cancer proliferation in many tissues, including the breast. Negative EYA2 expression in BC has been associated with aggressive tumors and poor prognosis.
Aim
This study aimed to investigate the immunohistochemical expressions of EYA2 and its relationship with different clinicopathological parameters, molecular types, and to evaluate their prognostic significance further. Patients and Methods Immunohistochemical expressions of EYA2 were examined in 60 randomly selected cases of invasive duct carcinoma.
Results
Positive EYA2 immunostaining was detected in 40% of cases and showed significant associations with higher tumor grade ( P =0.029), stage ( P
Zitieren
APA
Toni, N. D., Tawfik, H. M., & Zaher, A. M. A. (2025). Eyes absent homolog 2 in breast cancer: the relationship between molecular phenotyping and survival outcomes. Egyptian Journal of Pathology, 45(2), 123-130. https://doi.org/10.4103/egjp.egjp_15_25
Vancouver
Toni ND, Tawfik HM, Zaher AMA. Eyes absent homolog 2 in breast cancer: the relationship between molecular phenotyping and survival outcomes. Egyptian Journal of Pathology. 2025;45(2):123-130. doi:10.4103/egjp.egjp_15_25
BibTeX
@article{Toni2025,
author = {Toni, Nisreen D.M. and Tawfik, Heba M. and Zaher, Azza M. Abdel},
title = {Eyes absent homolog 2 in breast cancer: the relationship between molecular phenotyping and survival outcomes},
journal = {Egyptian Journal of Pathology},
year = {2025},
volume = {45},
number = {2},
pages = {123--130},
doi = {10.4103/egjp.egjp_15_25}
}
EUVIMED